Search results for:
Vancouver Spine Surgeons Honoured with Spine Society Award
Vancouver Surgeons honoured with Spine Society Award for Pre-Surgical Photodisinfection Protocol VANCOUVER, BRITISH COLUMBIA - Mar. 11, 2019 Ondine Biomedical Inc. congratulates the Vancouver Coastal Health spine group, Vancouver Coastal Health Infection Control and Vancouver Spine Institute for being the recipient [...]
78% Reduction in Infection Rates Using Nasal Photodisinfection Therapy
78% Reduction in Infection Rates Using Nasal Photodisinfection Therapy VANCOUVER, BC - March 04, 2019 Ondine Biomedical Inc. announced that its antimicrobial Photodisinfection technology was recommended for routine use of surgical site infection prevention due to its efficacy and cost effectiveness. [...]
Ondine CEO Appointed to Canada’s National Research Council (NRC)
Ondine CEO Appointed to Canada's National Research Council (NRC) VANCOUVER, BRITISH COLUMBIA - Jan. 08, 2019 Carolyn Cross, Chairman and Chief Executive Officer of Ondine Biomedical Inc., was appointed to Canada’s National Research Council (NRC) for a second term. As a [...]
Ondine President Presents at RSM Photodynamic Therapy Symposium
Ondine’s President and CTO, Dr. Nicolas Loebel Presented at The Royal Society of Medicine (RSM) Photodynamic Therapy Symposium (London, England) VANCOUVER, BC – December 5, 2018 On Monday, November 26, 2018 Dr. Nicolas Loebel, President and Chief Technology Officer of Ondine [...]
Ondine Launches SurgENT™ for U.S. Chronic Sinus Sufferers
Ondine Biomedical Inc. Launches SurgENT™ for U.S. Chronic Sinus Sufferers VANCOUVER, BC, CANADA AND ATLANTA, GA - October 9, 2018 SurgENT™ was officially launched during the 64th Annual Meeting of the American Rhinologic Society in Atlanta, GA Ondine Biomedical, Inc., an [...]
FDA Grants QIDP Designation to Ondine for Nasal Photodisinfection System
FDA Grants “Qualified Infectious Disease Product” (QIDP) Designation to Ondine Biomedical Inc. Subsidiary for Their Nasal Photodisinfection System VANCOUVER, BC – October 03, 2018 The FDA designation provides five years of additional market exclusivity after approval for Ondine Biomedical Inc.’s nasal [...]
New Book By Advisory Member: The Human Microbiota in Health and Disease
New Book By Advisory Member: The Human Microbiota in Health and Disease VANCOUVER, BC – September 21, 2018 Ondine Biomedical Inc. congratulates its Medical Advisory Board member, Dr. Michael Wilson, emeritus Professor of Microbiology at University College London, on the release [...]
Two Canadian Companies Join Forces for Chronic Sinus Sufferers
Two Canadian companies join forces to bring Medical Innovation to Canada’s Chronic Sinus Sufferers VANCOUVER, BC – September 17, 2018 Ondine Biomedical, Inc., an innovative medical solutions company, today announced that they have entered into an exclusive agreement with Southmedic, Inc., [...]
The Honourable Jean Charest Appointed to Ondine Board of Directors
Ondine Biomedical Announces the Appointment of The Honourable Jean Charest, Former Premier of Quebec and Deputy Prime Minister of Canada to Board of Directors VANCOUVER, BC – Feb. 12, 2018 Mr. Charest is currently a partner in the law firm McCarthy [...]
Superbugs No Match for Photodisinfection Technology
Press Conference: Superbugs No Match for Ondine’s Photodisinfection Technology VANCOUVER, BC – January 31, 2018 Ondine Biomedical Inc. is set to announce a major advancement in the treatment and prevention of multi-drug resistant infections in healthcare facilities during a press conference [...]
For Media Information
Simon Vane Percy
Amanda Bernard
